Cargando…

Proteomic Analysis of Lung Cancer Types—A Pilot Study

SIMPLE SUMMARY: Tackling and curing cancer is still one of the most important challenges of biomedical research. Lung cancer is among the most diverse and lethal types, therefore identifying alterations in proteins participating in events leading to this disease is crucial. By analyzing and comparin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugár, Simon, Bugyi, Fanni, Tóth, Gábor, Pápay, Judit, Kovalszky, Ilona, Tornóczky, Tamás, Drahos, László, Turiák, Lilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179298/
https://www.ncbi.nlm.nih.gov/pubmed/35681609
http://dx.doi.org/10.3390/cancers14112629
_version_ 1784723240411725824
author Sugár, Simon
Bugyi, Fanni
Tóth, Gábor
Pápay, Judit
Kovalszky, Ilona
Tornóczky, Tamás
Drahos, László
Turiák, Lilla
author_facet Sugár, Simon
Bugyi, Fanni
Tóth, Gábor
Pápay, Judit
Kovalszky, Ilona
Tornóczky, Tamás
Drahos, László
Turiák, Lilla
author_sort Sugár, Simon
collection PubMed
description SIMPLE SUMMARY: Tackling and curing cancer is still one of the most important challenges of biomedical research. Lung cancer is among the most diverse and lethal types, therefore identifying alterations in proteins participating in events leading to this disease is crucial. By analyzing and comparing the tissue proteomics profile of small cell lung cancer, as well as non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma, large cell carcinoma) subtypes, following on-surface tryptic digestion, we aimed to identify the key dysregulated pathways. Proteins altered between cancerous and respective adjacent normal tissue were determined to reveal common and lung cancer type-specific changes. These proteins can contribute to a more precise classification of lung cancer and, following validation, can further improve the currently available diagnostic panels. ABSTRACT: Lung cancer is the leading cause of tumor-related mortality, therefore significant effort is directed towards understanding molecular alterations occurring at the origin of the disease to improve current treatment options. The aim of our pilot-scale study was to carry out a detailed proteomic analysis of formalin-fixed paraffin-embedded tissue sections from patients with small cell or non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma, and large cell carcinoma). Tissue surface digestion was performed on relatively small cancerous and tumor-adjacent normal regions and differentially expressed proteins were identified using label-free quantitative mass spectrometry and subsequent statistical analysis. Principal component analysis clearly distinguished cancerous and cancer adjacent normal samples, while the four lung cancer types investigated had distinct molecular profiles and gene set enrichment analysis revealed specific dysregulated biological processes as well. Furthermore, proteins with altered expression unique to a specific lung cancer type were identified and could be the targets of future studies.
format Online
Article
Text
id pubmed-9179298
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91792982022-06-10 Proteomic Analysis of Lung Cancer Types—A Pilot Study Sugár, Simon Bugyi, Fanni Tóth, Gábor Pápay, Judit Kovalszky, Ilona Tornóczky, Tamás Drahos, László Turiák, Lilla Cancers (Basel) Article SIMPLE SUMMARY: Tackling and curing cancer is still one of the most important challenges of biomedical research. Lung cancer is among the most diverse and lethal types, therefore identifying alterations in proteins participating in events leading to this disease is crucial. By analyzing and comparing the tissue proteomics profile of small cell lung cancer, as well as non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma, large cell carcinoma) subtypes, following on-surface tryptic digestion, we aimed to identify the key dysregulated pathways. Proteins altered between cancerous and respective adjacent normal tissue were determined to reveal common and lung cancer type-specific changes. These proteins can contribute to a more precise classification of lung cancer and, following validation, can further improve the currently available diagnostic panels. ABSTRACT: Lung cancer is the leading cause of tumor-related mortality, therefore significant effort is directed towards understanding molecular alterations occurring at the origin of the disease to improve current treatment options. The aim of our pilot-scale study was to carry out a detailed proteomic analysis of formalin-fixed paraffin-embedded tissue sections from patients with small cell or non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma, and large cell carcinoma). Tissue surface digestion was performed on relatively small cancerous and tumor-adjacent normal regions and differentially expressed proteins were identified using label-free quantitative mass spectrometry and subsequent statistical analysis. Principal component analysis clearly distinguished cancerous and cancer adjacent normal samples, while the four lung cancer types investigated had distinct molecular profiles and gene set enrichment analysis revealed specific dysregulated biological processes as well. Furthermore, proteins with altered expression unique to a specific lung cancer type were identified and could be the targets of future studies. MDPI 2022-05-26 /pmc/articles/PMC9179298/ /pubmed/35681609 http://dx.doi.org/10.3390/cancers14112629 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sugár, Simon
Bugyi, Fanni
Tóth, Gábor
Pápay, Judit
Kovalszky, Ilona
Tornóczky, Tamás
Drahos, László
Turiák, Lilla
Proteomic Analysis of Lung Cancer Types—A Pilot Study
title Proteomic Analysis of Lung Cancer Types—A Pilot Study
title_full Proteomic Analysis of Lung Cancer Types—A Pilot Study
title_fullStr Proteomic Analysis of Lung Cancer Types—A Pilot Study
title_full_unstemmed Proteomic Analysis of Lung Cancer Types—A Pilot Study
title_short Proteomic Analysis of Lung Cancer Types—A Pilot Study
title_sort proteomic analysis of lung cancer types—a pilot study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179298/
https://www.ncbi.nlm.nih.gov/pubmed/35681609
http://dx.doi.org/10.3390/cancers14112629
work_keys_str_mv AT sugarsimon proteomicanalysisoflungcancertypesapilotstudy
AT bugyifanni proteomicanalysisoflungcancertypesapilotstudy
AT tothgabor proteomicanalysisoflungcancertypesapilotstudy
AT papayjudit proteomicanalysisoflungcancertypesapilotstudy
AT kovalszkyilona proteomicanalysisoflungcancertypesapilotstudy
AT tornoczkytamas proteomicanalysisoflungcancertypesapilotstudy
AT drahoslaszlo proteomicanalysisoflungcancertypesapilotstudy
AT turiaklilla proteomicanalysisoflungcancertypesapilotstudy